Paige M. Fox, Ph.D. - Publications

2006 Virginia Commonwealth University, Richmond, VA, United States 
Microbiology Biology, Molecular Biology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Noto MJ, Fox PM, Archer GL. Spontaneous deletion of the methicillin resistance determinant, mecA, partially compensates for the fitness cost associated with high-level vancomycin resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52: 1221-9. PMID 18212094 DOI: 10.1128/Aac.01164-07  0.92
2007 Fox PM, Climo MW, Archer GL. Lack of relationship between purine biosynthesis and vancomycin resistance in Staphylococcus aureus: a cautionary tale for microarray interpretation. Antimicrobial Agents and Chemotherapy. 51: 1274-80. PMID 17242154 DOI: 10.1128/Aac.01060-06  0.92
2007 Nelson JL, Rice KC, Slater SR, Fox PM, Archer GL, Bayles KW, Fey PD, Kreiswirth BN, Somerville GA. Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis. Antimicrobial Agents and Chemotherapy. 51: 616-22. PMID 17130298 DOI: 10.1128/Aac.01057-06  0.92
2006 Fox PM, Lampen RJ, Stumpf KS, Archer GL, Climo MW. Successful therapy of experimental endocarditis caused by vancomycin-resistant Staphylococcus aureus with a combination of vancomycin and beta-lactam antibiotics. Antimicrobial Agents and Chemotherapy. 50: 2951-6. PMID 16940087 DOI: 10.1128/Aac.00232-06  0.92
Show low-probability matches.